Tìm kiếm
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030
DMIIRThêm vào danh sách theo dõi
0.081USD
+0.000+0.25%
Đóng cửa 07/02, 13:00（ET）Báo giá bị trễ 15 phút
0.00Vốn hóa
--P/E TTM
Thêm thông tin về Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 Công ty
Drugs Made In America Acquisition II Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The Company intends to search for business combination targets in the pharmaceutical industry. The Company is neither engaged in any operations nor generated any revenues.
Thông tin của Drugs Made In America Acquisition II Rights Exp 16 Sep 2030
Mã chứng khoánDMIIR
Tên công tyDrugs Made In America Acquisition II Corp
Ngày IPOSep 25, 2025
Giám đốc điều hànhStockwell (Lynn)
Số lượng nhân viên- -
Loại chứng khoánRight
Kết thúc năm tài chính- -
Địa chỉ1 East Broward Boulevard
Thành phốFT LAUDERDALE
Sàn giao dịch chứng khoánNASDAQ OMX - NASDAQ BASIC
Quốc giaUnited States of America
Mã bưu điện33301
Điện thoại19548703099
Trang web
Mã chứng khoánDMIIR
Ngày IPOSep 25, 2025
Giám đốc điều hànhStockwell (Lynn)
Lãnh đạo công ty của Drugs Made In America Acquisition II Rights Exp 16 Sep 2030
Tên
Tên/Chức vụ
Chức vụ
Tỷ lệ sở hữu cổ phần
Thay đổi
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Glenn Worman
Mr. Glenn Worman
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director
Independent Director
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director
Independent Director
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director
Independent Director
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Tên
Tên/Chức vụ
Chức vụ
Tỷ lệ sở hữu cổ phần
Thay đổi
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Glenn Worman
Mr. Glenn Worman
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director
Independent Director
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director
Independent Director
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director
Independent Director
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Câu hỏi thường gặp
Ai là năm cổ đông lớn nhất của Drugs Made In America Acquisition II Rights Exp 16 Sep 2030?
Năm cổ đông hàng đầu của Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 là: Ms. Lynn Stockwell